Yorkshire Lands $3.6M for Prostate Cancer Research | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK charity Yorkshire Cancer Research (YCR) has given £2.2 million ($3.6 million) to fund research at the University of York that will blend genomics and stem cells studies in an effort to understand the causes of prostate cancer.

The researchers will study the DNA sequences of prostate cancer cells to search for sequences involved in the disease and for molecular properties that allow the cancer to survive, spread, and resist treatment, YCR said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.

Sponsored by
Agilent Technologies

This online seminar will discuss a metagenomic assay to identify viruses and other pathogenic microorganisms in human tumor samples, with the aim of gaining a more comprehensive understanding of the role of the microbiome in cancer development and treatment.